WGS – genedx holdings corp. - class a (US:NASDAQ)
Stock Stats
News
HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting
Artificial Intelligence Powered Rare Disease Diagnosis Research Report 2025: Market to Surpass $5.5 Billion by 2029 on Accelerated Adoption of Predictive and Personalized Healthcare - Forecast to 2034 [Yahoo! Finance]
GeneDx (NASDAQ:WGS) had its price target raised by analysts at Wells Fargo & Company from $95.00 to $140.00. They now have an "equal weight" rating on the stock.
GeneDx to Participate in Upcoming Investor Conferences
Form 4 GeneDx Holdings Corp. For: Dec 01 Filed by: Feeley Kevin
Form 4 GeneDx Holdings Corp. For: Nov 24 Filed by: RUCH JOSHUA
Form 144 GeneDx Holdings Corp. Filed by: RUCH JOSHUA
Form SCHEDULE 13G/A GeneDx Holdings Corp. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
Form 4 GeneDx Holdings Corp. For: Oct 29 Filed by: Stueland Katherine
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.